Navigation Links
ALS Patients’ Own Stem Cells Show Promise as a Future Treatment Option
Date:2/8/2013

ural cells? The present study demonstrated in a convincing manner the promise of CD133+ cells obtained from affected individual with ALS to transform into cells with neural potential,” Dr. Martinez said.

The team collected CD133+ cells from 13 patients diagnosed with ALS and then grew the cells in the lab for a period lasting up to 48 hours. At the end of the two days, they saw an increase in neuronal proteins. This suggested that the stem cells were in the early stages of becoming neurons. Furthermore, the expression of some specific genes within the same time period indicated that the fate towards motor neurons, the neurons being destroyed in Lou Gehrig´s patients, was underway.

“No correlation was found between age, sex or ALS functional scale and the CD133+ stem cells response to the neuro-induction medium,” Dr. González-Garza said. “Therefore, we concluded that CD133+ stem cells from ALS patients are capable of differentiating into pre-neuron cells, as well as the stem cells from healthy subjects.”

“These new findings provide the scientific basis for the positive clinical observations in patients with ALS treated by autotransplantation with CD133+ cells in the frontal cortex. But more importantly, they also give credence to the field of stem cell transplantation in other potentially fatal neurodegenerative conditions,” Dr. Cuevas added.

“This study may help explain the positive clinical outcomes obtained by stem cell transplantation in ALS patients and suggest the potential of stem cell therapy for conditions such as stroke and Parkinson’s disease,” said Anthony Atala, M.D., Editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine.

###

The full article, “Differentiation of CD133+ stem cells from amyotrophic lateral sclerosis patients into pre-neuron cells,” can be accessed at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New method for producing precursor of neurons, bone and other important tissues from stem cells
2. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
3. Notre Dame researchers develop paint-on solar cells
4. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
5. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
6. In solar cells, tweaking the tiniest of parts yields big jump in efficiency
7. Mesenchymal Stem Cells Have New Cell Culture Environment
8. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
9. Scientists Discover How a Bacterial Pathogen Breaks Down Barriers to Enter and Infect Cells
10. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
11. Study dusts sugar coating off little-known regulation in cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015  Brooklyn residents now have a new ... pain and injuries. Nunzio Saulle , M.D., a ... of his NJS Physical Medicine and Rehabilitation (PM&R) practice ... March 5, 2015. Health Plus Management, LLC is managing ... at 1178 Flatbush Avenue. This new PM&R practice will ...
(Date:3/4/2015)... /CNW/ - Resverlogix Corp. (TSX:RVX) (the "Company") today ... research program with Emerald Logic, a leader ... Technology (FACET), Emerald Logic analyzed Resverlogix,s complete ... each of 798 patients who participated in ... SUSTAIN and ASSURE. The objective of this ...
(Date:3/4/2015)... Pa. , March 4, 2015 /PRNewswire/ ... services and technology provider, today announced that ... 10 countries convened at its annual European ... to discuss the use of ... challenges. BioClinica,s eClinical technologies include: the Microsoft ...
(Date:3/4/2015)... Lancée par l,Assistance ... en décembre 2011, l,étude collaborative française randomisée ... compare   l es microsphères en résine ... le carcinome hépatocellulaire avancé, a recruté plus de ...   ; les résultats sont attendus fin 2016. ...
Breaking Biology Technology:NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 2Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 3Resverlogix Collaborates with Emerald Logic to Identify Factors Driving Drug Response and Efficacy in Phase 2 Program 4BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6
... ,II. Product Components ,III. Materials to be ... of DNA from Whole Blood ,V. Protocol for ... Quantification of Amplified Products ,VII. Purification of Amplified ... , Contact Information , , , , ...
... Using siRNA for gene silencing is a, ... for preparing siRNA, such as chemical synthesis, in vitro transcription, ... cassettes. Irrespective, of which method ... to choose the siRNA target site. The guidelines below for choosing, ...
... , , ... , , This Application Note describes ... total RNA and fragmented cRNA by using,the Agilent 2100 bioanalyzer. The Eukaryote ... 28S/18S ratio in the,total RNA as well as detection of possible degradation. ...
Cached Biology Technology:Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 2Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 3Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 4Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 5Protocol for GenomePlex Whole Genome Amplification ,from Whole Blood 6siRNA Design Guidelines 2siRNA Design Guidelines 3siRNA Design Guidelines 4siRNA Design Guidelines 5siRNA Design Guidelines 6siRNA Design Guidelines 7Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 2Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 3Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 4Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 5Advancing the quality control methodology,to assess isolated total RNA,and generated fragmented cRNA 6
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), ... crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz ... production capacity to meet customer demand. ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by ...
(Date:1/22/2015)... WINSTON-SALEM, N.C. , Jan. 16, 2015  A man-made ... working memory and other mental capabilities in adults with ... a pilot study led by researchers at Wake Forest ... 60 adults diagnosed with amnesic mild cognitive impairment (MCI) ...
(Date:1/22/2015)... , Jan. 21, 2015  Analyst Report Issued by Small ... Brands report showed that planet-wide, transactions at merchants on the ... the total number of credit, debit, and prepaid cards reached ... were victims of fraudulent card usage in 2012, and credit ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... and Workgroup Scanners Recognized by ... the Leading Guide for Office ... Fujitsu Computer Products of,America, Inc., a market leader in ... scanners earned the "Editor,s Choice",designation in the Better Buys ...
... Bacteria save energy by producing proteins that moonlight, having ... the microbes from being killed. The moonlighting activity of ... resistant to a family of broad-spectrum antibiotics, according to ... journal Microbiology. "Glutamate racemase, or ...
... 2008The many recent reports documenting the therapeutic efficacy of ... disease may actually be describing non-specific therapeutic effects related ... response, according to a paper in the September 2008 ... Therapy , a peer-reviewed journal published by Mary Ann ...
Cached Biology News:Fujitsu Scanners Selected as 'Editor's Choice' in Better Buys for Business 2008 Scan-to-File Guide 2Fujitsu Scanners Selected as 'Editor's Choice' in Better Buys for Business 2008 Scan-to-File Guide 3Energy-saving bacteria resist antibiotics 2Previous claims of siRNA therapeutic effects called into question by report in human gene therapy 2
... Ambions MAXIscript In Vitro Transcription Kits ... 1 x 10 9 cpm/g. High ... in ribonuclease protection assays, in situ hybridization, ... be used for the synthesis of modest ...
Mouse H60 Allophycocyanin MAb (Clone 205326) ENTREZ GeneID: 15101...
... 250 ul (125 precipitations). ... easy pellet location.Efficient precipitation ... inert, compatible with most ... protocol. Category: DNA/RNA Synthesis ...
... for monitoring Aldolase tests. 2 levels ... targeted manufacturing values at 4 ± ... IU/L. 30-day shelf life once ... Level 1: 3 x 3 ml; ...
Biology Products: